TCRX TScan Therapeutics: Bozor kapitallashuvining balans qiymatiga nisbati

tscan.com (TCRX) - korporativ logo

GURU.Markets platformasidagi TScan Therapeutics (TCRX) narxlar grafigi, faoliyati T-hujayralar terapiyasini yaratishda ESG standartlarini joriy etish va bioetikaga qat'iy rioya qilishga asoslangan aktivning narxlar dinamikasini aks ettiradi. Biznesning o'sishi birlamchi xavfsizlik sinovlarining muvaffaqiyati va o'smaga qarshi nishonlarni aniqlash aniqligiga bog'liq bo'lib, ushbu ko'rsatkich 0.19 darajasida turibdi. Moliyaviy barqarorlik grantlar tomonidan qo'llab-quvvatlanadi, bu esa klinik tadqiqotlar jarayonini bozorning tez-tez uchraydigan tebranishlaridan himoya qiladi.

TScan Therapeutics, Inc. (TCRX) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

TCRX (TScan Therapeutics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari tscan.com|TCRX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi TScan|TCRX - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati TScan Therapeutics|TCRX - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati tscan.com|TCRX - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati TScan Therapeutics|TCRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati tscan.com|TCRX - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati TScan
Fundamental baholash:TCRX (TScan Therapeutics Inc)
TScan Therapeutics tayyor mahsulotlari

Ushbu koeffitsient TScan Therapeutics (TCRX) kompaniyasining bozor qiymatini uning sof aktivlariga solishtirib, biznesning haddan tashqari yuqori baholanganlik darajasini aniqlaydi. Biofarmatsevtika sohasi uchun ushbu farq patentlarga oid kutishlar va xalqaro dori vositalarini ro'yxatdan o'tkazish bilan bog'liq xatarlarni aks ettiradi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati grafigini tahlil qilish orqali investor aksiyaning fundamental kuchliligi chegarasini aniqlashi mumkin. Ushbu metrikaning pasayishi aktivlarning past baholanganligini yoki logistikaga nisbatan geosiyosiy bosimni signalizatsiya qilishi mumkin. Yakuniy qiymat stress ssenariylari ostida kompaniyaning real qiymatini baholashga yordam beradi.

Asosiy raqobatchilar

Kapitallashuvning sof aktivlarga nisbati BeiGene Ltd|halozyme.com (HALO) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|Champions Oncology, Inc. (CSBR) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati XBIT (XBiotech Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp (CVM)|Kapitallashuvning sof aktivlarga nisbati OS Therapies Incorporated|Bozor kapitallashuvining balans qiymatiga multiplikatori RADX (Radiopharm Theranostics Ltd)|Bozor qiymatining balans qiymatiga nisbati ARTV|Balans qiymatiga nisbatan bozor kapitallashuvi Adlai Nortye Ltd ANL|VERU: Bozor kapitallashuvining balans qiymatiga nisbati|TPST - Kapitallashuvning sof aktivlarga nisbati|XLO: Bozor kapitallashuvining balans qiymatiga nisbati|RENB (Renovaro) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Mural Oncology PLC (MURA)|Kapitallashuvning balans qiymatiga nisbati Kairos Pharma Inc (KAPA)|OnKure Therapeutics Inc (OKUR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati w2.cytomed.sg GDTC|Kapitallashuvning sof aktivlarga nisbati Curis (CRIS)|Bozor kapitallashuvining balans qiymatiga multiplikatori Apollomics Inc. APLM|Bozor kapitallashuvining balans qiymatiga nisbati Tharimmune (THAR)|ADVB - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|SBFM - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Xenetic Bio|Bozor kapitallashuvining balans qiymatiga nisbati SLRX|Bozor kapitallashuvining balans qiymatiga nisbati PPBT (Purple Biotech Ltd)|American Oncology Network, Inc. (AONC) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi BeiGene Ltd BGNE|CKPT (Checkpoint Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Elevation Oncology Inc. (ELEV) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ICAD: Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ikena Oncology|Notable Labs Inc. (NTBL) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Viracta|MOR (MorphoSys AG) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi nayabiosciences.com (NAYA)|Ascentage Pharma - Bozor kapitallashuvining balans qiymatiga nisbati